The second NPC approval in a week highlights the FDAs commitment to supporting the development of innovative therapies for rare diseases, Janet Maynard, director of the FDAs Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, said in a statement
Additionally, it has been demonstrated that the combination of docetaxel and R162 inhibits the development and metastasis of non-small cell lung cancer cells resistant to docetaxel, hence bolstering the effectiveness of combination therapy including anticancer medications and GLUD1 inhibitors as a cancer treatment approach [111]
It improves sagging skin and helps with reducing fine lines, wrinkles, and sun damage, promoting skin firmness
Metal ion binding, contribution to fibrillization and toxicity
identified that heat shock protein B1 (HSPB1) is a novel regulator in VSMC ferroptosis